Stock abbreviation: Shanghai Aladdin Biochemical Technology Co.Ltd(688179) Stock Code: Shanghai Aladdin Biochemical Technology Co.Ltd(688179) Shanghai Aladdin Biochemical Technology Co.Ltd(688179)
Shanghai Aladdin Biochemical Technology Co.,Ltd.
(No. 809, Chuhua Branch Road, Fengxian District, Shanghai)
Issue convertible corporate bonds to unspecified objects
Listing announcement
Sponsor (lead underwriter): Western Securities Co.Ltd(002673)
(room 10000, building 8, No. 319, Dongxin Street, Xincheng District, Xi’an City, Shaanxi Province)
April, 2002
Section I important statements and tips
Shanghai Aladdin Biochemical Technology Co.Ltd(688179) (hereinafter referred to as ” Shanghai Aladdin Biochemical Technology Co.Ltd(688179) ,” issuer “,” company “or” the company “) all directors, supervisors and senior managers guarantee the authenticity, accuracy and completeness of this listing announcement, promise that there are no false records, misleading statements or major omissions in the listing announcement, and bear individual and joint legal liabilities for the authenticity, accuracy and completeness of its contents.
In accordance with the provisions of the company law of the people’s Republic of China, the securities law of the people’s Republic of China and other relevant laws and regulations, the directors and senior managers of the company have fulfilled their obligations and responsibilities of integrity and diligence according to law. The opinions of China Securities Regulatory Commission (hereinafter referred to as “CSRC”), Shanghai Stock Exchange (hereinafter referred to as “Shanghai Stock Exchange”) and other government authorities on the listing and related matters of the company’s issuance of convertible corporate bonds (hereinafter referred to as “convertible bonds”) to unspecified objects do not indicate any guarantee to the company. The company reminds investors to pay attention to the relevant contents not involved in this listing announcement. Investors are invited to refer to the summary of Shanghai Aladdin Biochemical Technology Co.Ltd(688179) offering convertible corporate bonds to unspecified objects published in Shanghai Securities News on March 11, 2022 and the website designated by Shanghai Stock Exchange (http: / / www.sse. Com. CN.) The full text of Shanghai Aladdin Biochemical Technology Co.Ltd(688179) the prospectus for issuing convertible corporate bonds to unspecified objects (hereinafter referred to as the “prospectus”) and the relevant materials of this issuance.
Unless otherwise specified, the abbreviation used in this listing announcement has the same interpretation as the prospectus.
Shanghai Stock Exchange has formulated the necessary provisions for the disclosure of investment risks of convertible corporate bonds issued to unspecified objects. From October 26, 2020, if investors participate in the purchase transaction of convertible bonds issued to unspecified objects, they shall sign the disclosure of investment risk of convertible corporate bonds issued to unspecified objects (hereinafter referred to as “risk disclosure”) in paper or electronic form. If the investor fails to sign the risk disclosure statement, the securities company shall not accept its subscription or purchase entrustment. The foregoing requirements are not applicable to professional investors who meet the requirements of the measures for the administration of the appropriateness of securities and futures investors, directors, supervisors and senior managers of the convertible bond issuer, and shareholders with a shareholding ratio of more than 5% who apply for and trade the convertible bonds issued by the issuer.
Investors who participate in the convertible bonds of Kechuang board can buy or sell the convertible bonds they hold. However, investors who do not meet the requirements for the appropriateness management of stock investors on the science and innovation board cannot convert their convertible bonds on the science and innovation board into stocks. Investors need to pay attention to the risks and possible impact of their convertible bonds not being able to convert into stocks due to their failure to meet the requirements for the appropriateness management of stock investors on the science and innovation board.
Section II overview
1、 Convertible corporate bonds: Allah convertible bonds
2、 Convertible corporate bond Code: 118006
3、 Issuance of convertible corporate bonds: 387.4 million yuan (387400 hands)
4、 Listing volume of convertible corporate bonds: 387.4 million yuan (387400 hands)
5、 Listing place of convertible corporate bonds: Shanghai Stock Exchange
6、 Listing time of convertible corporate bonds: April 12, 2022
7、 Starting and ending dates of convertible corporate bonds: from March 15, 2022 to March 14, 2028
8、 Start and end date of convertible corporate bonds conversion: the convertible bonds conversion period of this issuance starts from the first trading day (September 21, 2022) after the expiration of six months from the issuance end date (March 21, 2022, t + 4) to the maturity date of convertible bonds (March 14, 2028) (in case of legal holidays or rest days, it will be extended to the first working day thereafter; the interest payment during the extended period will not be calculated separately).
9、 Interest payment date of convertible corporate bonds: the interest payment date of each year is the date of each full year from the first date of issuance of convertible corporate bonds. If the day is a legal holiday or rest day, it shall be postponed to the next trading day without additional interest. The interest year is between two adjacent interest payment days.
The interest payment creditor’s right registration date of each year is the trading day before the interest payment date of each year. The company will pay the interest of the current year within five trading days after the interest payment date of each year. For the convertible corporate bonds that apply for conversion into the company’s shares before the registration date of interest paying creditor’s rights (including the registration date of interest paying creditor’s rights), the company will no longer pay the interest of this interest year and subsequent interest years to its holders.
The tax payable on the interest income obtained by the holders of convertible corporate bonds shall be borne by the holders.
10、 Registration authority of convertible corporate bonds: China Securities Depository and Clearing Co., Ltd. Shanghai Branch (hereinafter referred to as “China Clearing Shanghai Branch”)
11、 Sponsor (lead underwriter): Western Securities Co.Ltd(002673)
12、 Guarantee of convertible corporate bonds: the convertible corporate bonds issued this time do not provide guarantee. 13、 Credit rating and credit rating agency of convertible corporate bonds: the convertible corporate bonds issued by the company are rated by China Securities PENGYUAN credit rating Co., Ltd. according to the credit rating report on issuing convertible corporate bonds to unspecified objects in Shanghai Aladdin Biochemical Technology Co.Ltd(688179) 2021 issued by China Securities PENGYUAN credit rating Co., Ltd. (Zhongpeng credit rating [2021] No. Z [1370]), the main credit rating of the company is a +, The credit rating of the convertible bonds issued this time is a +, and the rating outlook is stable.
After the convertible bonds issued this time are listed, during the duration of the bonds, CSI PENGYUAN credit evaluation Co., Ltd. will track and rate the credit status of the bonds regularly or irregularly, and issue a tracking and rating report. Regular follow-up rating shall be conducted at least once a year during the duration of the bond.
Section III introduction
This listing announcement is prepared in accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the measures for the administration of securities issuance and listing recommendation business, the measures for the administration of securities issuance and registration of companies listed on the science and Innovation Board (for Trial Implementation), the Listing Rules of shares on the science and Innovation Board of Shanghai Stock Exchange and other relevant laws and regulations.
With the consent of the CSRC’s zjxk [2022] No. 72 document, the company issued 3.874 million convertible corporate bonds to unspecified objects on March 15, 2022, with a face value of 100 yuan each and a total issuance amount of 387.4 million yuan. The convertible bonds issued this time are preferentially placed to the original shareholders registered by China Clearing Shanghai branch after the closing of the market on the equity registration date (March 14, 2022, t-1). The balance after the priority placement of the original shareholders (including the part of the original shareholders giving up the priority placement) is issued to the public investors through the trading system of Shanghai Stock Exchange, and the balance is underwritten by the sponsor (lead underwriter).
With the consent of self regulatory decision [2022] No. 88 of Shanghai Stock Exchange, the company’s 387.4 million yuan convertible corporate bonds will be listed and traded in Shanghai Stock Exchange from April 12, 2022. The bonds are referred to as “ala convertible bonds” for short and the bond code is “118006”.
Section IV overview of the issuer
1、 Basic information of the company
Chinese name Shanghai Aladdin Biochemical Technology Co.Ltd(688179)
English Name: Shanghai Aladdin Biochemical Technology Co., Ltd
The registered capital is 75.7 million yuan
Legal representative: Xu Jiuzhen
Address: No. 809, Chuhua Branch Road, Fengxian District, Shanghai
Office address: 16th floor, South Tower, No. 36, Xinjinqiao Road, Pudong New Area, Shanghai
Technology development, technical consultation, technical service and technology transfer in the field of chemical reagents, biological reagents and bioengineering products, sales of instruments and glass products, R & D, production and distribution of chemical reagents (including drug intermediates, additives, biological reagents and electronic chemicals) Retail (excluding hazardous chemicals, MCCs, fireworks and firecrackers, civil explosives and precursor chemicals), production and sales of disinfection products for infectious disease prevention and control, wholesale of hazardous chemicals (see the attached page of the license for the scope of license), import and export of goods and technology, and operation of medical devices. (except for the items that must be approved according to law, the company shall independently carry out business activities according to law with its business license)
The main business is the R & D, production and sales of scientific research reagents, and supporting a small amount of experimental consumables
Industry M73 research and test development
Tel: 02150560989
Fax 02150323701
E-mail [email protected].
Secretary of the board of directors Zhao Xin’an
2、 Historical evolution and equity changes (I) establishment
1. Establishment of limited company
On December 8, 2008, the shareholders Xu Jiuzhen, Zhao Liping, Yang mingzhan and Jingchun reagent jointly held a shareholders’ meeting and made a resolution, agreed to establish Shanghai Jingchun Industrial Co., Ltd. and agreed to adopt the articles of association of Shanghai Jingchun Industrial Co., Ltd.
According to the articles of association of Shanghai Jingchun Industry Co., Ltd., the registered capital of Jingchun industry at the time of its establishment was 500000 yuan, of which Jingchun reagent contributed 250000 yuan in currency, accounting for 50% of the registered capital; Xu Jiuzhen’s goods
RMB 100000, accounting for 20% of the registered capital; Yang mingzhan contributed 100000 yuan in currency, accounting for 20% of the registered capital; Zhao Liping contributed 50000 yuan in currency, accounting for 10% of the registered capital.
On March 10, 2009, Shanghai Anhua Da Certified Public Accountants issued the capital verification report (Hu’an kuaiyan [2009] ynf3-138): after verification, as of March 9, 2009, Jingchun industry had received a total of 500000 yuan of registered capital paid by Jingchun reagent, Xu Jiuzhen, Yang mingzhan and Zhao Liping, all of which were invested in currency, including 250000 yuan of Jingchun reagent, 100000 yuan of Xu Jiuzhen Yang mingzhan contributed 100000 yuan and Zhao Liping contributed 50000 yuan.
On April 7, 2020, Dahua Certified Public Accountants (special general partnership) issued Shanghai Aladdin Biochemical Technology Co.Ltd(688179) capital verification review report (dahuahe Zi [2020] No. Jikai Equipment Manufacturing Co.Ltd(002691) ): after review, the capital contribution is consistent with the capital verification report Hu’an kuaiyan [2009] No. ynf3-138 issued by Shanghai anhuada certified public accountants.
On March 16, 2009, Jingchun industry obtained the business license of enterprise legal person (Registration No.: 31022 Greattown Holdings Ltd(600094) 0881) issued by Fengxian branch of Shanghai Administration for Industry and commerce, with a registered capital of 500000 yuan. The capital contribution of Jingchun industry at the time of establishment is as follows:
Serial number shareholder name / name contribution amount (10000 yuan) contribution proportion (%)
1 crystal pure reagent 25.00 50.00
2 Xu Jiuzhen 10.00 20.00
3 Yang mingzhan 10.00 20.00
4 Zhao Liping 5.00 10.00
Total 50.00 100.00
2. Establishment of joint stock company
Jingchun industry was changed to Jingchun biochemical in October 2013. Shichuang investment, Xu Jiuzhen, Yang mingzhan and Zhao Liping, all shareholders, as sponsors, established a joint stock limited company with the overall change of audited net assets into shares of Jingchun industry as of July 31, 2013.
On August 31, 2013, the overall change of Jingchun industry was approved by the fifth extraordinary shareholders’ meeting of Jingchun industry in 2013
